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Current health care standards, in many countries, Australia included, are 
regrettably poor. Surprisingly, practitioners and treating teams alike in mental 
health and disability sectors, in particular, make far too many basic care-
related mistakes, in addition to the already abundant diagnostic mistakes that 
cause and amplify great harm. In part, too many practitioners also fail to 
distinguish adverse effects for what they are and all too often treat adverse 
effects, instead, as comorbidities. Diagnostic failures are dangerous, the result 
of which generates and perpetuates harms that are extremely costly in terms 
of patient welfare, in addition to the financial burden placed on everyone. In 
this essay, I contend that the authority bestowed upon psychiatry is misplaced. 
Subsequently, this misplaced authority affects the governing and investigatory 
institutions reliant and informed by psychiatry. The examination process 
undertaken in this investigation traces the metaphysics of psychiatric 
disorders relative to the Diagnostic-Statistical-Manual (DSM) in all its 
iterations and to the epistemological construction process that serves to 
underpin the fundamentals of psychiatric practice. There exists a crisis of 
confidence in psychiatric practice and I urge drastic reform be undertaken to 
arrest the damage.   
  






Current standards of Health Care concerning mental health, aged care, and 
disability sectors, are extremely poor and severely deficient warranting Royal 
Commissions recently in Australia. Poor standards involving diagnostic inflation, 
polypharmacy, questionable use of restrictive practices, abuse, segregation and 
exploitation. There are those fortunate enough to have good care, good carers and 
good clinical practitioners in the mix. „It‟s not a total mess‟, some might say! Yet, 
the very nature and shape of mental health and disability relative to the associated 
services has been influenced largely by psychiatry seemingly without enough 
regard for the inherent methodological problems bedevilling it as a clinical 
practice. All fields of medicine are fallible, some more than others are subject to 




inexact practices weakened by their own theoretical and methodological 
deficiencies. Psychiatry, for its presumed authority, however, is a special case in 
point that requires specific attention. The literature emerging within the ranks of 
psychiatry, collectively, and aptly named Critical Psychiatry, testifies to the 
internal concerns regarding the profession and its practice disclosing serious 
methodological deficiencies. What is not generally made public is the number of 
individuals who have lost their lives as a direct consequence of poor clinical, often 
coerced, psychiatric drug-centred treatment and mismanagement. In America, 
according to Psychiatrist Allen Frances, there were more deaths “due to legal 
prescription drugs than from illegal street drugs” (2013, p. xv). We should note 
that Frances played an integral role in the development of the Diagnostic and 
Statistical Manual (DSM), specifically DSM-III, DSM-IIIR and DSM-IV. In 
Australia, as reported by the Australian Bureau of Statistics (ABS) (2018) „3303.0 
Causes of Death, Australia, 2016 Report‟ released 15 May 2018, suicide statistics 
are on the rise and though several socioeconomic factors are involved mental 
illness as constructed and conveyed from within psychiatry permeates our social 
psyche and its memes penetrating all areas of human interaction. These worrying 
suicide trends are worst in the United States where it is legal for the Pharmaceutical 
industry to market directly to consumers. Risk of overdose increases when 
individuals take both benzodiazepines and opioids yet despite the risk, “rates of 
coprescribing nearly doubled, increasing from 9% in 2001 to 17% in 2013” 
(Lembke, Papac, and Humphreys, 2018, p. 694). Psychiatry, by and large, 
presupposes that:  
 
generalizable psychopathological entities exist that can be demarcated and that 
individuals who are categorized in a particular way share much in common with 
others who are assigned the same diagnosis. It assumes that mental disorders can be 
characterised independently from other characteristics of the individual who is 
affected. This was and is a hypothesis (Moncrieff & Steingard, 2019, p. 4.).  
 
Vast cultural diversity and immeasurable variation among individuals makes 
such reductionist assumptions challenging to verify, among an array of other 
epistemic challenges. Yet in practice, this ill-conceived assumption nonetheless 
largely underpins general psychiatric clinical and prescriptive practices. 
Complications emerge as echoed by Johann Hari‟s research published in 2018 
Lost Connections: Uncovering the Real Causes of Depression and the Unexpected 
Solutions. Hari draws upon empirical research and presents these findings in an 
accessible manner. When it comes to depression psychiatrists do understand that 
the causes can be wide and varied. Some people experience depression due to 
environmental, social and psychological concerns, as such are classified as 
“reactive depression”. Others, experience depression due to internal physical 
concerns, as such are classified as “endogenous depression” (Hari, 2018, p. 52). 
Hari describes a clinical trial that involved a comparative analysis of two groups: a 
group diagnosed with „reactive depression‟ and a group diagnosed with 
„endogenous depression‟, evidently, the result was: „no difference between them‟. 
One common factor was discovered between the two defined groupings; the 
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common factor was „trauma‟ and the “generalisation of hopelessness” featured as 
a distinctive variable. Repeated clinical trials, as Hari reports, undertaken some 
years later to investigate the causes of depression in places radically different as 
rural Zimbabwe and rural Spain, produced the same findings. In sum, where there 
exist strong community ties, like rural Spain, depression is very low, consistent 
with people who have less traumatic experiences and, in such community‟s, this 
acts to protect people against depression. In contrast, in areas where trauma is 
high, community ties withered, as then rural Zimbabwe, it was found that these 
factors were driving depression (Hari, 2018, p. 52). 
As such, in this essay I examine the nature of mental health disorders as 
distinguished between „endogenous‟ (predisposed/genetic) and „reactive‟ forms by 
interrogating the ontology of mental disease/disorders, the psychosocial and 
psychosomatic mechanisms of symptom manifestation, coupled with an 
examination of the epistemological mechanisms commonly employed by 
psychiatrists when constructing diagnostic claims regarding the nature of mental 
disease/disorders that will ultimately affect treatment options. To this end, I 
provide a brief review of the practice of diagnosis and the continuing attendant 
substantiation problems, specifically verification, validity, and reliability of 
diagnosis, as associated with psychiatry. What ensues are six main points of 
concern identified as „over-diagnosis‟ or „diagnostic-inflation‟, „polypharmacy‟, 
„harm perpetrated by clinical mismanagement‟, „harm by coercion‟, mistaking 
„trait‟ for „state‟, and referring to „adverse effects as comorbidities‟. These 
concerns are bi-products arising from methodological deficiencies bedevilling 
psychiatry made worse by misguided clinical practitioners. I conclude that the 
„curse of expertise‟ (Robson, 2019) and the misplaced authority afforded 
psychiatry contributes, whether by design or accident, towards the exacerbation of 
disability and mental-health social ills. This misplaced authority indeed errantly 
legitimates the ill-conceived narratives, as propagated through its Diagnostic-
Statistical-Manual (DSM) in all iterations, psychiatry‟s detailed construction and 
list of disorders and their proffered treatments largely influenced by the outreach 
of the pharmaceutical industry (Frances, 2013; Whitaker, 2015; Steingard, 2019). 
 
Psychiatry: What is it all about? 
 
Debate regarding the etiology and treatment of major mental disorders, a 
debate with a long history, still rages between biological psychiatry and 
psychological psychiatry (Preston and Johnson, 2019, p. 1). Historically, in 
tandem with the influential growth of DSM-III Diagnostic system, was an 
increasing application and administration of drug treatments in line with 
„psychiatric diagnostic inflation‟ (Frances 2013). This adaptation became the 
primary therapeutic mode of psychiatry. Heavily influenced by the pharmaceutical 
industry, the prevalence of drug treatments contributed to the conceptual 
legitimacy of psychiatry as a medical branch under the impression it was sustained 
by having delineated pathological conditions targetable by using disease-specific 
treatments, as in medicine” (Moncrieff & Steingard, 2019, p. 4). For example, in 
the United States “since 2005 there have been a remarkable eightfold increase in 




psychiatric prescriptions among our active duty troops”. In the general population, 
“antidepressant use nearly quadrupled from 1988 to 2008 (Frances, 2013. p. xv). 
Worryingly, far too many problems associated with psychiatry are rampant. In 
practice, during an examination the clinician should be considering to what extent 
the presentation of a patient/client with some concern is due to psychological 
factors (reactive), and if so, mostly does not require drugs for treatment, or to what 
extent the concern is due to an endogenous (genetic) disturbance in which case 
often drugs may be required. (Preston and Johnson, 2019, p. 1). This is the general 
area where the controversy largely lies whilst also generating reason for the crisis 
of confidence in psychiatry for so often, in the diagnosis stage, serious decision-
making errors are made and that leads to patient/consumer mismanagement. 
Similarly, in the United States there is little effort:  
 
to address inappropriate prescribing of benezodiazepines – controlled substances such 
as alprazolam, clonazepam, diazepam, and lorazepam. The Food and Drug 
Administration (FDA) has approved benzodiazepines for a diverse set of clinical 
indications, including anxiety, insomnia, seizures, and acute alcohol withdrawal” 
(Lembke, Papac, and Humphreys (2008, p. 693).  
 
To appreciate the gravity of this challenging concern requires considering 
psychometric use of psychological terms. Psychometric tests are designed to show 
someone‟s personality, mental ability, opinions and such like. One such important 
distinction is between „traits‟ and „states‟. „Traits‟ refer to “broad and stable 
dispositions” regarded in two ways: as “either „physical properties‟, such as visual 
acuity, strength, agility, etc. or „psychological properties‟, such as „intelligence‟ 
and „rationality‟. „States‟, in contrast, are regarded as temporary qualities 
characterised by changeable moods, and is by definition, understandably quite 
broad. For example, when a person who may start the day feeling happy, hears 
terrible news and becomes “sad, or angry and the like” (Ackerman & Beier, 2006. 
p. 147). Pertinently, what constitutes a „state‟ includes anything that induces or 
disrupts one‟s mood, and that includes anything that causes stress or trauma, not 
least, a disruption caused by the administration of some causal agent, like 
psychiatric drugs. During consultation if the clinician fails to distinguish „trait‟ 
from „state‟, the likelihood of misdiagnosis increases substantially. Step wise the 
consequences arising from a mistaken diagnosis, increases the risk of over-
diagnosis, and at each step inappropriate treatment being administered to a patient. 
Because reaction to types of drugs varies among the population clinicians 
prescribe through a trial and error drug changing regime, hence concomitantly 
increasing the risk of exacerbating the patient‟s existing distress or trauma. This, 
disconcertingly, is the standard modus operandi for psychiatrists.      
 
An Ontological Consideration of the Conditions that give Rise to Mental Disorders  
 
Statistically, if a higher percentage of individuals treated by psychiatrists 
employing a drug-centred versus a disease-centred approach to pharmacotherapy, 
as longitudinal studies suggest, (Davies, 2014; Frances, 2013; Steingard, 2019; 
A Metaphysical and Epistemological Critique of Psychiatry   
 
133 
Whitaker, 2015) are worse off than they were prior to being treated by a 
psychiatrist, then something is wrong with the epistemic assumptions underpinning 
disability and mental illness and subsequent drug-centred treatments adopted. As 
such, this raises questions regarding those consumers reported as benefitting from 
the services of psychiatrists. How is benefit perceived, and what really underlies 
the success, if that is what it really is, for them? Since irrespective of which class 
of psychiatric drug is examined the themes are the same, “short term efficacy with 
increased relapse risk when drugs are stopped, combined with a conceptualization 
of mental disorders as chronic, leads to recommendations for long-term drug use” 
(Steingard, 2019, p. 129). Most, if not all, psychiatric drugs are addictive. 
Mysteriously, unwary practitioners fail to distinguish „withdrawal symptoms‟ and 
can instead misconstrue those symptoms describing them in terms of „relapse‟ 
which indeed is quite a common mistake or denial (Breggin, 2013, p. 14-16). 
Antipsychotic withdrawal reactions include persisting tardive psychosis, emotional 
lability, instability, abnormal movements, and cognitive dysfunction, 
symptomatically relative to the type of drug and administration duration in one‟s 
system (Breggin, 2013 pp. 124-125). In practice this amounts to an integrity 
concern since the harm perpetrated should carry an onus of responsibility by an 
accountable diagnostician. Addictive drug diminishment or discontinuation of 
drug through tapering requires a slow attenuation process over a long period, and 
in order to minimise potential harm the duration of each reduction-step needs close 
monitoring and attention. Drug tapering requires appropriate medical supervision 
to monitor the patient‟s health and metabolic resolve. What can be identified is 
that lax governance and poor regulation necessitated to address the enormous 
management problem of clinicians underreporting adverse-effects/events, 
omissions dismissively occurring on a global scale (Robertson, & Newby, 2013) 
adds support for the need to reform and to arrest the ill-conceived practice. By no 
means unique to Australia, the Pharmaceutical Society of Australia (PSA) released 
their report in January 2019 titled PSA Medicine Safety: Take Care, which 
specified the scope of harms in Australia resulting from medicine use. “The report 
reveals that 250,000 Australians are hospitalised each year, with another 400,000 
presenting to emergency departments, as a result of medication errors, 
inappropriate use, misadventure and interactions”. Half of these were preventable. 
“…the report calculates the annual cost of medication-related problems in Australia 
at nearly $1.4 billion – equivalent to 15 per cent of total PBS expenditure” (PSA, 
2019). 
In fact, these concerns extend beyond psychiatry, exposing significant 
theoretical and clinical practice deficiencies surrounding medicine, generally 
speaking, but rendered particularly more onerous for psychiatry because their 
authority to enforce the Mental Health Act and to coerce patient compliance to 
advised treatment is regularly occurring irrespective of the harm perpetrated upon 
patients/consumers. This indicates a common perceptual failing committed by 
clinicians, a kind of cognitive dissonance manifesting as a failure to recognise, 
understand, and to act clinically responsibly and appropriately. This is sufficient 
reason to seek regulatory reform of psychiatry to ensure greater oversight and 
overall clinician accountability for ill-conceived and dangerous clinical practices. 




This may require re-evaluating current education practices to include extended 
pharmacological training along with appropriate critical and reflective thinking 
education as essential to psychiatry certification and registration. Currently, 
psychiatrists can force treatment on two grounds:  
 
1) a person has a „mental disorder‟ which warrants treatment;  
2) the person needs treatment in the interest of his/her safety or for the 
protection of others.  
 
As analysed by George Szmukler in Men in White Coats: Treatment Under 
Coercion, these two grounds are in and of themselves rather slippery notions 
classified under „Detention and Treatment – the „Risk-criterion‟ and the „Mental-
disorder-criterion‟ (2018, p. xvii). Psychiatrists are afforded an all imposing 
authority, operating too often with absolute impunity, in effect subjugating the 
individual into coerced compliance which essentially strips away the individual‟s 
humanity. The relationship between psychiatrist and consumer/client, even when 
using the term patient, is authoritarian and is rendered so from an antiquated 
paternalistic model that treats the individual as a subject for treatment disregarding 
ones humanity, autonomy and dignity. 
Psychiatric drugs are psychoactive agents and they function to alter normal 
mental functions, despite the paucity of attention given to this fact. It is implausible 
to believe that these effects “have no impact on the thoughts and behaviours that 
constitute the criteria for mental-disorders” (Moncrieff, 2019, p.105). In reference 
to the highly contentious drug-centred treatment model:  
 
“…instead of prescribing treatments for particular conditions, psychiatrists 
should see themselves as offering drugs which produce drug-induced states 
which people may or may not find helpful. In order to do this conscientiously, 
prescribers need to have comprehensive information about the sort of state 
that different drugs induce as well as the full consequences of taking them 
over short and longer periods” (Moncrieff, 2019, p. 105).  
 
Psychiatrist Joanna Moncrieff explains that research on psychiatric drugs 
is limited to the focus on the disease-centred model. There is a dearth of 
information regarding both the scope of effects from these drugs and the range 
of iatrogenic harm produced by their continued ingestion. Little is known about 
“what it feels like to take them; physiological and biochemical research has 
focused on their effects on presumed disease mechanisms, such as dopamine or 
serotonin receptor levels, and ignored the many other effects that drugs have” 
(Moncrieff, 2019, p. 105). Recently, some attention can be identified in certain 
sectors providing discussion forums to include information from people with 
lived experience, but this is nonetheless a slow progress and requires an attitudinal 
shift of gigantic proportions. Convergent research is seemingly ignored by 
what cognitive scientists call „earned dogmatism‟ referring to those with assumed 
expertise who think they have earned the right to ignore other perspectives. A 
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case in point, Pharmacogenetics, provides valuable information about an 
individual‟s capacity to effectively metabolise drugs administered to them:    
 
Cytochrome P450 enzymes are essential for the metabolism of many 
medications. Although this class has more than 50 enzymes, six of them 
metabolize 90 percent of drugs, with the two most significant enzymes being 
CYP3A4 and CYP2D6. Genetic variability (polymorphism) in these enzymes 
may influence a patient‟s response to commonly prescribed drug classes, 
including beta blockers and antidepressants. Cytochrome P450 enzymes can 
be inhibited or induced by drugs, resulting in clinically significant drug-drug 
interactions that can cause unanticipated adverse reactions or therapeutic 
failures. Interactions with warfarin, antidepressants, antiepileptic drugs, and 
statins often involve the cytochrome P450 enzymes (Lynch & Price, 2007, p. 
391). 
 
Many psychiatrists, as evidenced in terms of diagnostic-inflation, 
polypharmacy and other identified inappropriate medication concerns, are either 
unaware or simply ignore this biophysical understanding. Indeed, yet many it 
appears, seemingly persist with their own entrenched drug-treatment options. 
Simple non-invasive genetic tests can be easily conducted to not only establish a 
patient‟s capacity to metabolise a prescribed drug, serving to recognise drug-to-
patient compatibility, but additionally to minimise unintended drug adverse harm, 
whilst mitigating costly existing trial and error drug changing debilitating practices.            
This next section extends further into the ontology of mental illness to explore 
identifiable reasons for misinterpretation and consequent misdiagnosis problems. 
This will involve examining the sorts of conditions that arise from psychosocial 
stressors that may lead to the manifestation of psychosomatic symptoms for one 
class of mental disorders as distinguished from assumed endogenous conditions 
expressed when triggered by relative factors.    
 
Mental Illness: Mind and Matter of Concern 
 
The foundational ideas underpinning what constitutes mental illness have a 
long history across diverse fields of enquiry. Whilst characteristically relative 
to poor mental health, mental illness is, let us bear in mind, also an ever increasing 
and very profitable phenomena driven by a mental health industry operating in 
tandem with the pharmaceutical industry. To examine what and how mental 
illness generally is understood I adopt a philosophical model of investigation 
by focusing on the epistemic foundations and ontological nature of mental illness. 
Some definitions are required to contextualise the following methodological 
reasoning. Epistemology is the branch of philosophy dealing with knowledge. 
Typical questions are about what knowledge is, what types there are, how it is 
acquired, specific methods of enquiry, including recognising limits to knowing. 
Usually this study involves concepts such as truth, validity, justification, 
verification, and reliability, among other ideas. Every field of human enquiry has 
an epistemic foundation. The term „science‟ is derived from Latin „scientia‟, 




which translates the Greek „episteme‟, into the English rendition of 
„epistemology‟. Epistemic notions invariably are directed towards or represent 
something. “Words refer to something; perception (aesthesis in Greek) involves 
perceptibles; knowledge requires a known. In this respect, epistemology cannot be 
investigated without regard to what there is” (Silverman, 2014). This leads us into 
Metaphysics, which is the branch of philosophy that studies being qua being. 
Aristotle, one of the earliest theorists, on examining being indicated that we 
understand the way anything that is by how it „can be said of another‟ or be 
„present in another‟ or „thought to be of another‟ (Studtmann, 2008). Thus 
indicating there are several ways of being which additionally enabled Aristotle to 
produce a classification system, referred to as „ontology‟; “the English suffix „-
ology‟ signifying „study of‟: e.g., biology is the study of living things” (Silverman, 
2014). 
Mental illness is conceptualised in a variety of ways but we can draw upon 
medicine to consider pertinent terminology to contextualise what gives rise to 
mental illness. Hence, the term „etiology‟ refers to the source of something, medical 
or not, the origination. The associated term „pathology‟ has two senses: firstly, by 
referring to the science of the causes and effects of diseases and secondly, by 
referring to the branch of medicine that deals with the laboratory examination of 
samples of body tissue for diagnostic or forensic purposes. „Biomarkers‟ are the 
indicators that can be “measured accurately and reproducibly”. Biomarkers serve as 
“most objective, quantifiable medical signs modern laboratory science allows us to 
measure reproducibly” (Strimbu and Tavel, 2011 p. 463). When we think about 
„mental illness‟, general descriptions refer to a wide range of mental health 
conditions - disorders that affect your mood, thinking and behaviour. Typically 
mental illness includes: anxiety disorders, schizophrenia, depression, addictive-
behaviours and eating-disorders. These conditions, however, are also highly 
controversial phenomena on several fronts attracting much disagreement within 
the health sciences. In any case, poor mental health becomes a mental illness when 
persistent signs and symptoms cause frequent stress and affect your ability to 
function. The central procedure employed to detect a disease is called „diagnosis‟ 
which involves identifying the nature of an illness or other concern by examining 
the symptoms to establish what kind of phenomenon (genus/species) is causing the 
disruption which often involves the second sense of pathology covered above.  
For psychiatry two major concerns are manifestly evident: firstly, “though, 
„concerted‟ research efforts in the „decade of the brain‟ and the years that followed 
have unravelled critical insights on the pathogenesis of psychiatric disorders, 
clinically translatable biomarkers in psychiatry are yet to be identified” (Venkata-
subramanian and Keshavanb, 2016 p. 3). The absence of clinically identifiable 
biomarkers that would otherwise provide verification or the physical basis for 
assumed disorders, are fundamental for making valid diagnosis, and; secondly, 
psychiatry suffers from a lack of sophisticated diagnostic tools specifically 
effecting the reliability of diagnosis (Davies 2013; Moncrieff, 2008). Far from 
exhaustive these inherent and serious diagnostic deficiencies in themselves mar 
psychiatry. Considerable reliance is placed on three aspects for test of diagnosis 
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when evaluating its validity: „content validity‟, „construct validity‟, and „criterion-
related validity‟. Analysis of these three tests reveal fundamental epistemic 
weaknesses. To identify these weaknesses we first examine how each validity test 
is constituted. „Construct validity‟ is a relational concept which refers to the degree 
to which a construct captures „reality‟ or „nature‟. „Content validity‟ tests whether 
the way a construct is operationalised, as in the symptoms included in the checklist 
or ontological category for a particular disorder, is an adequate reflection of the 
construct as a whole; for example, symptoms listed in DSM-5 for Major 
Depressive Disorder (MDD)) (Karter and Kamens, 2019 pp. 47-48). „Criterion-
related validity‟ involves „prediction‟, for example, to test the validity of MDD in 
the DSM-5 is tested by considering whether the operationalised construct predicts 
the outcomes as expected to predict in theory/ies. However, there are several 
theories for depression and several variables involved that give rise to a broad 
margin of error (Karter and Kamens, 2019, pp. 47-48) as indicated above between 
endogenous and reactive manifestations of symptoms. 
Research indicates that great effort has gone into understanding the many 
issues regarding validity and reliability of psychiatric diagnosis that need 
resolving. Recently, scholars and clinicians, collaborated to produce a rich and 
varied analysis of the central concept of validity culminating in the publication of 
Alternative Perspectives on Psychiatric Validation: DSM, ICD, RDoC, and Beyond 
(2015). This body of work addresses the „crisis of confidence in psychiatric 
diagnostic concepts‟ inviting an appreciation for the complexity associated with 
the claim that diagnostic criteria, however they may differ, „define a valid 
psychiatric disorder‟. Psychiatrists themselves have identified many problems and 
inconsistencies in the DSM, that indeed a “crisis of confidence has become 
widespread … inside the field. The problems with the current diagnostic paradigm, 
some psychiatrists believe, has become so great that a significant paradigm shift 
may be required” (Zachar & Jablensky, 2015, p. 9). In this context „reliability‟ 
refers to the amount of agreement between independent clinicians who may gather 
for case analysis concerning the diagnosis of an individual patient. There are 
serious inherent problems associated with an over-reliance on this procedure that 
incorporates several forms of biases, pressure from external industry influences, 




Diseases caused, at least in part, by psycho-emotional factors are referred 
to as psychosomatic disorders. Psychosomatic disorders occur most often when 
repeated emotional stress impedes normal function and leads to dysfunction or 
structural damage in the body‟s tissues and organ systems by damagingly 
triggering the involuntary nervous system and glands. A common example is a 
headache ordinarily associated with a common cold or from muscle tension in 
reaction to stress. When associated with a common cold, as the infection subsides, 
the headache usually disappears. But headaches arising from continued emotional 
stress may be self-perpetuated. Not uncommon! A person experiencing muscle 
tension in the neck, shoulders, and back produced by continued worrying will 




effectively serve to increase stress. Causes of psychosomatic disorders have their 
roots in thought processes, but the physical manifestation of symptoms are real, 
can be serious, and even life threatening. Though there is some interest in 
psychosomatic medicine a paucity of understanding and research still remains to 
be undertaken and this failing generates additional problems. James, J. Strain 
(2017) from the Icahn School of Medicine at Mount Sinai in his report, 
Globalization of Psychosomatic Medicine, cautions that:    
 
Ubiquitous medical and psychiatric comorbities demand that not just specialists but 
all doctors in the world understand the interactions of medical and psychiatric drugs 
whether they be pharmacodynamic or pharmacokinetic. In a survey of 100 patients 
seen on a consultation-liaison service, Adson et al. found that the mean number of 
medications prescribed per patient was 8.8. Eighty-seven were taking drugs that were 
CYP450 enzyme inhibitors, and 14 were on substrates vulnerable to elevated serum 
levels from co-prescribed CYP450 inhibiting drugs. In another study 70% were 
receiving a drug that can alter the function of two major metabolic enzymes – 3A4 
and 2D6 thus potentially causing clinically relevant drug–drug interactions. Such 
studies demonstrate the need to disseminate this information to all physicians because 
of its impact on the well-being of patients worldwide. Entire countries and even 
continents are bereft of organized systems to promote psychosomatic and the 
psychological care of the medically ill information.  
 
On further analysis “… somatic symptom disorders (having pronounced 
somatic symptoms without objective somatic signs) [occurring] in childhood and 
adolescence [reportedly] have experienced traumatic events, such as physical or 
sexual abuse, major loss, natural disasters or have been witnesses to violence. 
Recent studies are focusing attention on the role of attachment and post-traumatic 
symptomatology for a better evaluation of this disorder” (Makieieva, N., Penkov, 
A., Marabyan, R., Kholodova, M., Vasheva, I., 2014).  
Similarly, Andrzej Brodziak (2015) appraises the situation from the point of 
view of the psychosomatic paradigm, indicating that: 
  
…the psychopathologic and social factors are essential to the development, 
prevention, and treatment of most diseases and clinical situations, the cursory 
overview of the articles most downloaded from websites of the two top mainstream 
medical journals (The New England Journal of Medicine and The Lancet) suggests 
that these substances do not attract much attention for authors and readers of these 
journals. This should prompt an accurate analysis of “characteristics and trends” of 
many medical journals regarding the appreciation of a psychosomatic approach.  
 
Though there is a growing awareness of psychosomatic illnesses there 
remains a gap and need for greater attention and understanding required to 
improve health services. Psychosomatic or self-induced symptoms have long been 
the subject of fascination for many within the fields of philosophy of mind, 
psychology, and meditative schools of thought. On closer scrutiny, integral to this 
examination is the role of emotion and particularly the role of imagination, or 
more so, an over-active imagination, at play for the generation of phobias and 
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other psychosomatic disorders. Recent research within the Neurosciences is 
making ground towards identifying the neural pathways associated with the 
imagination. The neurological pathways between a real and imagined experience 
run in opposite directions but the same brain areas are involved. The brain might 
use different directional pathways, if that is truly the case, but nonetheless, the 
main point is that there will be an effect depending on the stressors or stimulus – 
indeed translatable to psychophysical information received or transmitted.  
Throughout history many natural philosophers have pondered the question: 
does the brain, can the brain, recognise the difference between what it imagines 
and what it perceives as real? Both are experiences? A physicalist employing a 
reductive analysis will endeavour to locate the central brain structure responsible 
for interpreting the combination of information converging from interoceptive, 
proprioceptive, kinaesthetic, and somatosensory transmissions, from around the 
body to establish that which determines the difference between real and imagined. 
Since, if we take into consideration an evolutionary perspective, it is recognised 
that the „stress response‟ evolved in humans to enhance the ability to fight, flee or 
freeze, when confronted with perceived danger as associated with certain types of 
beliefs. Physiologically requiring the secretion of chemicals including cortisol and 
adrenalin to stimulate the body, intensifying blood flow towards major muscles to 
provide strength for defence, for escaping or to freeze (O‟Sullivan, 2015). Though 
an extremely convincing account, pointedly, the same stress response is induced 
by imagining danger, likewise producing cortisol and adrenalin and intensifying 
the flow of blood within the body. Whether the danger is real or imagined matters 
not because the same chemistry ensues. What does this mean in terms of mental 
health? Your brain does not, in every instance, distinguish between what you 
imagine or experience as real, and if this exercise of thinking a certain way 
persists, then that may cause disruption and contribute to deleterious physiological 
and behavioural effect. Having an overactive imagination can be confusing for 
some and be particularly challenging during certain developmental stages of life. 
An over-active imagination can concomitantly be emotionally charged, 
characteristically manifesting for some, as low self-esteem, lack of confidence, tics 
and tremors, anxiety, insecurity, and a host of other disruptions.   
  Determining whether an experience is real or imagined involves a subjective 
dimension of reality-checking requiring additional areas of the brain and bodily 
input. At certain developmental stages many will experience precarious times 
when trying to come to terms with a sense of their own one-self. The brain 
recognises and responds to information whether imagined or real according to 
sensory experience, but either way, whether sensory or imagined, it is nonetheless 
psychophysical information. This information leads to reactive or heightened 
states triggering physiological processes that alter the body‟s normal functioning 
that, if sustained, can produce unwanted negative effects, phobias and behavioural 
changes. There is a long history and pertinent philosophical understanding to draw 
upon. One such example can be traced back to the ancient Stoics‟ understanding of 
fear – they recognised fear can cripple a person in battle (Solomon, 2003). 
Certainly not dissimilar to contemporary notions of catatonia as a reactive 
condition triggered by fear, trauma, and a clinically recognised common adverse 




effect from psychiatric drugs (Zachar and Jablensky, 2015, p. 8; Kolk, 2014, p. 23-
25).  
It is not my intention to place all psychiatrists in the same basket especially 
not those seeking reform. However, adverse effects such as Focal Dystonia, for 
example, is a condition in which people‟s muscles go into spasm, can certainly be 
triggered by trauma and exacerbated by certain psychiatric drugs. From this 
perspective insight is drawn from psychiatrist, Bessel Van der Kolk‟s work 
articulated in The Body Keeps the Score: Mind, Brain and Body in the 
Transformation of Trauma (2014). Kolk laments that too many psychiatrists and 
clinicians fail to recognise the symptoms of trauma that errantly leads to 
misdiagnose and mismanaging their patients. Inadvertently perhaps, though in 
effect, aiding the generation of adverse effects consequently misinterpreted as 
comorbidities. He is not only pointing to bad clinical management practices but 
also adding voice to the need and attention given to how psychiatrists are trained 
and educated. A concern echoed by Allen Frances (2013) who critically suggested 
that “the right goal for DSM-5 would have been diagnostic restraint and deflation, 
not a further unwarranted expansion of diagnosis and treatment” (p. xviii). As 
mentioned above he laments that there are “more deaths from prescribed drugs 
than from illegal street drugs... When their product are used carelessly the drug 
companies can be as dangerous as the drug cartels” (2013 p. xv).  
Though not exhaustive, in the mix there are other considerations in terms of 
mind-producing effects and one in particular is the Placebo effect phenomenon. 
The Placebo effect occurs, as generally recognised, during drug testing trials when 
patients think they are receiving a new drug, although in many instances they may 
well be in the group administered a sugar pill. In cases like these it appears that it 
is a matter of „mind over medicine‟, because many people begin to recover from 
their ailment as though they had received real medicine. It is pertinent to ask what 
role the imagination plays under these circumstances. But it does not end there 
because there is another phenomenon which functions in the opposite direction to 
the placebo effect called the nocebo effect. In this case, a person receives a sugar 
pill, but deceptively is told that the pill is a new drug that has known adverse 
effects. Intriguingly, in this scenario, the pill administered is really only a sugar pill 
which matters not because in these cases the person begins to exhibit those 
previously described adverse symptoms. Not surprisingly, during any procedure or 
surgery, standard clinical practice requires that the patient be informed of possible 
risks associated with the surgery or procedure. Being informed of the risks in 
many instances can negatively impact one‟s recovery and this phenomenon is 
thought to be associated with psychosomatic triggers actuated more often when 
emanating from a perceived authority. Similarly, much literature has been devoted 
to the „Milgram experiment‟ and other research corollary‟s regarding perceived 
authority and consequent reciprocated compliance so I will not rehearse that here 
because the white-lab-coat phenomenon is well understood in everyday medical 
practices. 
In conclusion I have shown in this essay that psychiatry as a clinical practice 
suffers operational deficiencies that warrant major concern and necessarily requires 
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serious consideration to review the authority bestowed upon its practitioners. I 
have argued that this medical authority is misplaced since psychiatry operates from 
a fundamentally flawed epistemic framework and for the inherent deficiencies 
effecting the capacity of its practitioners to effectively and consistently clinically 
diagnose what indeed constitutes disorders in an ontologically sound way. 
Currently, psychiatry is a misaligned practice not congruent with what would 
otherwise constitute medical expertise. Substantiation concerns were highlighted 
through a review of the practice of diagnosis and the continuing attendant 
problems, specifically identified were verification, validity, and reliability of 
diagnosis of so-called psychiatric illnesses. Six main points of concern were 
identified as „over-diagnosis‟ or, „diagnosis-inflation‟, „prolonged harm caused by 
drug induced adverse effects‟, as generated by „clinical mismanagement‟ for too 
often mistaking „state‟ for „trait‟. In an indirect manner it becomes evident that 
psychiatry‟s misplaced authority legitimates „harm by coercion‟, and this also 
involves a major concern at the heart of the ethical integrity of the practice. 
Additionally for referring to „adverse effects from psychiatric drugs as comorbities‟ 
which indeed results in a vicious cycle of polypharmacy, harm on a large scale 
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